American Journal of Obstetrics & Gynecology
Volume 195, Issue 1 , Pages 85-91 , July 2006

Communicating contraceptive effectiveness: A randomized controlled trial to inform a World Health Organization family planning handbook

  • Markus J. Steiner, PhD

      Affiliations

    • Family Health International, Research Triangle Park, NC
    • Corresponding Author InformationReprint requests: Markus Steiner, PhD, Family Health International, PO Box 13950, Research Triangle Park, NC 27709.
    • ,
  • James Trussell, PhD

      Affiliations

    • Office of Population Research, Princeton University, Princeton, NJ
    • ,
  • Neha Mehta, MPH

      Affiliations

    • Family Health International, Research Triangle Park, NC
    • ,
  • Sean Condon, DrPH

      Affiliations

    • Family Health International, Research Triangle Park, NC
    • ,
  • Sumathi Subramaniam, MPH

      Affiliations

    • Independent Consultant, Bangalore, India
    • ,
  • Deborah Bourne, MA

      Affiliations

    • Hope Enterprises Ltd, Kingston, Jamaica

Received 1 September 2005 ,Revised 19 December 2005 ,Accepted 22 December 2005.

References 

  1. Grady WR, Klepinger DH, Nelson-Wally A. Contraceptive characteristics: the perceptions and priorities of men and women. Fam Plann Perspect. 1999;31:168–175
  2. Little P, Griffin S, Kelly J, Dickson N, Sadler C. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial. BMJ. 1998;316:1948–1952
  3. Edwards JE, Oldman A, Smith L, McQuay HJ, Moore RA. Women's knowledge of, and attitudes to, contraceptive effectiveness and adverse health effects. Br J Fam Plann. 2000;26:73–80
  4. Steiner MJ, Dalebout S, Condon S, Dominik R, Trussell J. Understanding risk: a randomized controlled trial of communicating contraceptive effectiveness. Obstet Gynecol. 2003;102:709–717
  5. Snow R, Garcia S, Kureshy N, Sadana R, Singh S, Becerra-Valdivia M, et al. Attributes of contraceptive technology: women's preferences in seven countries. Reprod Health Matters. 1997;special issue:36-44
  6. Sadana R, Snow R. Balancing effectiveness, side-effects and work: women's perceptions and experiences with modern contraceptive technology in Cambodia. Soc Sci Med. 1999;49:343–358
  7. Garcia S, Snow R, Aitken I. Preferences for contraceptive attributes: voices of women in Ciudad Juarez, Mexico. Int Fam Plann Perspect. 1997;23:52–58
  8. O'Connor AM, Legare F, Stacey D. Risk communication in practice: the contribution of decision aids. BMJ. 2003;327:736–740
  9. O'Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003;(2):CD001431
  10. Chewning B, Mosena P, Wilson D, Erdman H, Potthoff S, Murphy A, et al. Evaluation of a computerized contraceptive decision aid for adolescent patients. Patient Educ Couns. 1999;38:227–239
  11. Trussell J. Contraceptive efficacy. In:  Hatcher RA,  Trussel J,  Stewart F,  Nelson AL,  Cates W,  Guest F, et al. editor. Contraceptive technology. 18th ed.. New York: Ardent Media Inc; 2004;p. 773–845
  12. Trussell J. Contraceptive failure in the United States. Contraception. 2004;70:89–96
  13. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191–1194
  14. Grisaffe DB, Shellabarger S. Consumer comprehension of efficacy data in four experimental over-the-counter label conditions. Drug Inf J. 1997;31:937–961
  15. European Commission. A guideline on the readability of the label and package leaflet of medical products for human use. European Commission Pharmaceutical Committee; Brussels: 1998. Available at: http://pharmacos.eudra.org/F2/eudralex/vol-2/C/gl981002.pdf. Accessed 24 January 2006.
  16. Berry DC, Raynor DK, Knapp P, Bersellini E. Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scales. Drug Saf. 2003;26:1–11

 Supported by the William and Flora Hewlett Foundation.

PII: S0002-9378(05)02752-3

doi: 10.1016/j.ajog.2005.12.053

American Journal of Obstetrics & Gynecology
Volume 195, Issue 1 , Pages 85-91 , July 2006

Article Tools

* Image Usage & Resolution